Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Marie‐Nicole Theodoraki; Saigopalakrishna S. Yerneni; Thomas K. Hoffmann; William E. Gooding; Theresa L. Whiteside

doi:10.1158/1078-0432.ccr-17-2664

December 12, 2017Clinical Cancer ResearchOpen Access

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Circulating PD-L1high exosomes in HNC patients' plasma but not soluble PD-L1 levels associate with disease progression. Clin Cancer Res; 24(4); 896-905.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Theodoraki et al. (2017) studied this question.

synapsesocial.com/papers/69dd3a650644c7b49d40c6aa https://doi.org/10.1158/1078-0432.ccr-17-2664

View Full Paper

Ask AI

Bookmark

Share

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Abstract

Ask about this paper

Discussion

Cite This Study

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading